ESR1 and prostate carcinoma: Moreover, androgen receptor-negative prostate cancer cells PC-3 and DU145, estrogen-receptor positive breast cancer cells MCF7 and triple-negative breast cancer cells MDA MB 231 were also sensitive to Super-EBS (Fig. S1F).